Related Experiment Video
Updated: Jul 6, 2026
06:26
Novel and Innovative Hybrid Technique for Type A Aortic Dissection
Published on: March 28, 2025
Aortic stent grafts.
G S Soor1, M O Chakrabarti, J R Abraham
1Department of Pathology, Toronto General Hospital, University Health Network, Toronto, Canada.
Journal of Clinical Pathology
|March 8, 2008
Summary
Abdominal aortic aneurysms (AAAs) are treated with endovascular aneurysm repair (EVAR), offering lower risks than open surgery. Analyzing explanted devices aids future AAA stent development and complication awareness.
Area of Science:
- Vascular Surgery
- Biomedical Engineering
- Medical Device Analysis
Background:
- Abdominal aortic aneurysms (AAAs) involve weakened aortic walls, with risk factors including smoking, atherosclerosis, and hypertension.
- Traditional open surgery for AAAs has been largely superseded by endovascular aneurysm repair (EVAR) due to its reduced perioperative risks.
Purpose of the Study:
- To review FDA-approved and emerging endovascular aneurysm repair (EVAR) stent devices.
- To highlight the importance of analyzing explanted devices for future EVAR technology and complication insights.
Main Methods:
- Review of FDA-approved EVAR stent devices.
- Analysis of data from explanted EVAR devices.
- Discussion of potential future EVAR device developments.
Main Results:
- EVAR demonstrates significant advantages over open repair, particularly in lower morbidity and mortality rates.
- Continued analysis of explanted EVAR devices is crucial for device improvement and understanding complications.
- Numerous FDA-approved EVAR stents are available, with more anticipated from clinical trials.
Conclusions:
- EVAR is the preferred treatment for abdominal aortic aneurysms, with ongoing evolution expected to further decrease complications.
- Detailed analysis of explanted EVAR devices is essential for advancing vascular repair technologies and patient safety.
